/
We are a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. Our products are designed to achieve our goal of providing better clinical outcomes at a lower overall cost for healthcare systems.
Operating margin is thin at 7.08%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 19.0% YoY with margins expanding 5.6pp.
Net debt of $32M represents 14.6x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$107M
▲ +19.0% YoY
Net Income (TTM)
-$34M
▼ -288.7% YoY
Op. Margin
8.49%
▲ +5.6pp YoY
ROIC
11.82%
▲ +9.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3M
▲ +1041.1% YoY
Op. Cash Flow (TTM)
$6M
▲ +28634.4% YoY
Net Debt
$35M
Cash & Equiv.
$14M
5Y CAGR: +45.9%
Continue Research